pcDNA3.1-KozATG-dH6.2-2XG4S-actin
(Plasmid
#73263)
-
PurposeExpresses dH6.2-actin fusion within mammalian cells. (dH6.2, FAP)
-
Depositing Lab
-
Depositing OrganizationCarnegie Mellon University
Located in United States of America -
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 73263 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
| DNA | 73263-D50 | 50 μg of DNA in Tris buffer | $495 | ||
| DNA | 73263-D100 | 100 μg of DNA in Tris buffer | $585 | ||
Backbone
-
Vector backbonepcDNA3.1
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5382
- Total vector size (bp) 7458
-
Modifications to backboneThe NdeI site was removed from the CMV promoter
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Growth instructionsNo special instructions.
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameKozATG-dH6.2-2XG4S-actin
-
Alt namedH6-actin
-
SpeciesH. sapiens (human), Synthetic
-
Insert Size (bp)2070
-
MutationThe dH6.2 FAP has one cysteine in each domain changed to an alanine
-
Entrez GeneACTB (a.k.a. BKRNS, BNS, BRWS1, CSMH, DDS1, PS1TP5BP1, THC8)
- Promoter CMV
-
Tag
/ Fusion Protein
- The FAP and actin are fused with 2 copies of a G4S linker
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer CMVF
- 3′ sequencing primer BGHR
- (Common Sequencing Primers)
Resource Information
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit the Molecular Biosensor and Imaging Center website for current protocols and information about dyes to be used in combination with the proteins expressed from this plasmid.
DNA (Catalog # 73263-D50)
Purpose
Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.
Delivery
- Amount 50 μg
- Concentration 1 μg/μL
- Pricing $495 USD
- Storage 4 ℃ (short-term) or -20 ℃ (long-term)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Quality Control
Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.
Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.
DNA (Catalog # 73263-D100)
Purpose
Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.
Delivery
- Amount 100 μg
- Concentration 1 μg/μL
- Pricing $585 USD
- Storage 4 ℃ (short-term) or -20 ℃ (long-term)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Quality Control
Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.
Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA3.1-KozATG-dH6.2-2XG4S-actin was a gift from Marcel Bruchez (Addgene plasmid # 73263 ; http://n2t.net/addgene:73263 ; RRID:Addgene_73263) -
For your References section:
Localization microscopy using noncovalent fluorogen activation by genetically encoded fluorogen-activating proteins. Yan Q, Schwartz SL, Maji S, Huang F, Szent-Gyorgyi C, Lidke DS, Lidke KA, Bruchez MP. Chemphyschem. 2014 Mar 17;15(4):687-95. doi: 10.1002/cphc.201300757. Epub 2013 Nov 5. 10.1002/cphc.201300757 PubMed 24194371